Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
The Impact of Calibration Needs on Collision Repair
With the increasing ubiquity of Advanced Driver Assistance Systems (ADAS), comes the increasing need for systems to be properly calibrated to ensure proper functionality after a repair has taken place. In many instances, calibrations are required simply because there is damage in the general area of a particular component, even if it wasn’t directly impacted by the collision event.
Create Rules that Drive Accurate and Proper Repairs with Estimate Advisor
As vehicle technology continues to change, having a Compliance Tool that has the ability to create flexible and detailed rules is a must.
Mitchell Announces Simplified Implementation for ClaimIQ Liability and Injury Software
Mitchell introduces new ClaimIQ liability and injury software implementation options to increase accessibility for additional insurance carrier types.
Mitchell Issues 1st Quarter 2020 Industry Trends Report
Electric car sales grow but repairs remain costly; workers' compensation predictions for 2020; claims technology and the human touch.
Is there a new concern related to Gabapentin use and serious breathing problems?
In a drug safety communication from FDA Medwatch, the FDA warns about serious breathing difficulties related to the use of gabapentinoid (GabaP) medications in patients with other respiratory risk factors.1
Current Used Vehicle Market Conditions: Q4 2019
2019 ended with average wholesale prices dropping for the seventh month in a row. Though some of this decline reflects seasonal patterns, it may also be indicative of used vehicle market “fatigue” after many months of admirably withstanding used vehicle supply growth without significant deterioration in values.